Filter Results:
(611)
Show Results For
- All HBS Web
(1,026)
- People (4)
- News (257)
- Research (611)
- Events (9)
- Multimedia (24)
- Faculty Publications (398)
Show Results For
- All HBS Web
(1,026)
- People (4)
- News (257)
- Research (611)
- Events (9)
- Multimedia (24)
- Faculty Publications (398)
Sort by
- 05 Jul 2004
- Research & Ideas
Radical Change, Entrepreneurial Opportunity
tightly coupled relationships with customers to engage in trials of different product concepts, producers and users can jointly learn about and make sense of the new technology. For instance, Surface Logix, a firm with highly sophisticated, flexible technology called... View Details
- 15 Jun 2016
- Research & Ideas
These VC Partners May Make Your Firm Less Innovative
developed by the Food and Drug Administration (FDA), they were able to tell which companies were competitors in the same patient application areas (such as cardiology, oncology, or urology) and product classes. Then, using commercial... View Details
- 25 Aug 2015
- First Look
First Look Tuesday
to examine the phenomena in the context of health. In particular, we examine how an individual's prior experiences and the experiences of those around them alter the operational decisions that the individual makes. We draw on an exogenous announcement of negative news... View Details
- 05 Nov 2007
- Research & Ideas
The Changing Face of American Innovation
on? Are they concentrated in a specific industry or business type? A: Inventors can file for patents in many technology fields, ranging from chemicals and drugs to computer software to agricultural machinery. Immigrant contributions are... View Details
- 25 Oct 2016
- First Look
October 25, 2016
insulate consumers from cost sharing, thereby undermining insurers’ ability to influence drug utilization. We study the impact of copay coupons on branded drugs first facing generic entry between 2007 and... View Details
Keywords: Sean Silverthorne
- 07 Aug 2007
- First Look
First Look: August 7, 2007
and issues around current practices. Purchase this note: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=807124 U.S. Food and Drug Administration Harvard Business School Note 807-050 Describes the U.S. FDA with particular... View Details
Keywords: Martha Lagace
- 26 Apr 2004
- Research & Ideas
A Clear Eye for Innovation
series of contact-lens products, introduced a drug for treating age-related macular degeneration, pioneered a new lens-manufacturing process that dramatically reduced production costs, and overtook J&J in some market segments. The... View Details
- 15 Feb 2000
- Lessons from the Classroom
Delivering Information Services: A 30-Year Perspective
IPO in 1990 to a $10-billion company today, with a market value of close to $140 billion! I'm also doing research for a case on Drugstore.com, which is essentially a drug store "built" on the Internet. It's getting ready to... View Details
Keywords: by Staff
- 07 Aug 2006
- Research & Ideas
Whatever Happened to Caveat Emptor?
basic material needs to concerns about the safety and quality of these products. When products did fail—as happened dramatically in the late 1950s with the antinausea drug Thalidomide—such cases became the focus of aggressive consumer... View Details
- 15 Dec 2014
- Research & Ideas
Deconstructing the Price Tag
expenses incurred. For example, R&D expenditures in the pharmaceutical industry involve more than just the cost of producing one particular drug. Many drugs may have to fail before one succeeds, and that one hit View Details
- 27 Jan 2003
- Research & Ideas
New Cluster Mapping Project Helps Companies Locate Facilities
A: There is some heartening progress. The word is out among retailers about the under-served market in inner cities. Drug chains, such as Walgreen's, and many other retailers, such as Home Depot, are pursuing this opportunity to good... View Details
Keywords: by Sean Silverthorne
- 21 Jul 2015
- First Look
First Look: July 21, 2015
new drug markets. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=49384 Cases & Course Materials Harvard Business School Case 715-438 The Transformation of NCR During his tenure as CEO since 2005, Bill Nuti... View Details
Keywords: Sean Silverthorne
- 20 May 2016
- Op-Ed
World Health Organization Lacks Leadership to Combat Pandemics
greater role in WHO governance and if there are guarantees of purchase contracts for new drugs and vaccines at sensible prices. Both seem unlikely, as the WHO's culture has always winced at cooperation with the private sector. WHO's track... View Details
- 14 Jul 2006
- Op-Ed
The Case for Consumer-Driven Medicaid
diabetic and asthmatic enrollees due to increased testing and drug utilization, while management consulting firm McKinsey found that consumer-driven enrollees were more likely to "very carefully follow treatment regimens for chronic... View Details
Keywords: by Regina E. Herzlinger
- 18 Apr 2017
- First Look
First Look at New Ideas, April 18
M&A) and Werner Baumann (CFO) have to decide whether to increase the cash portion of their $14.2 billion offer and/or amend the terms of a proposed joint venture (JV) with Merck involving cardiovascular drugs that had been included in... View Details
Keywords: by Sean Silverthorne
- 28 Jul 2009
- First Look
First Look: July 28
report, new CEO Hank McKinnell discusses Pfizer's performance goals and its acquisition of Pharmacia, which gave it control of the anti-arthritis drug Celebrex. In the 2005 report, McKinnell discusses his decision to keep Celebrex on the... View Details
Keywords: Martha Lagace
- 30 Oct 2007
- First Look
First Look: October 30, 2007
Changing Context of Pharmaceutical Risk Mitigation Author:Arthur A. Daemmrich Periodical:Pharmacy in History 49, no. 2 (2007): 61-75 Abstract In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side... View Details
Keywords: Sean Silverthorne
- 22 Aug 2006
- First Look
First Look: August 22, 2006
805-067 Molecular Insight has developed a novel biopharmaceutical to detect heart attacks. The company's unique approach to intellectual property protection uses the Hatch Waxman Act and the Orphan Drug Act. The company is struggling to... View Details
Keywords: Martha Lagace
- 17 Sep 2001
- Research & Ideas
Why E-commerce Didn’t Die With the Fall of Webvan
drugs for chronic conditions—from pharmacies to a combination of direct mail and telephone. The idea was that if you have a chronic condition, you're in a replenishment mode. You have to fill the prescription regularly over a number of... View Details
- 12 Nov 2024
- HBS Case
Inside One Startup's Journey to Break Down Hiring (and Funding) Barriers
mouths have an opportunity to do something like Harley’s doing?” A prison conviction leads to multiple employment rejections After losing his father at age 15, Blakeman fell into hard drug use. After he was incarcerated in a Georgia... View Details